<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sickle cell disease acute chest syndrome (ACS) clinical features and management implications in children and adults</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sickle cell disease acute chest syndrome (ACS) clinical features and management implications in children and adults</h1>
<div class="graphic"><div class="figure"><div class="ttl">Sickle cell disease acute chest syndrome (ACS) clinical features and management implications in children and adults</div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup span="2" width="40%"></colgroup> <tbody> <tr> <td class="subtitle1"> </td> <td class="subtitle1">Children</td> <td class="subtitle1">Adults</td> </tr> <tr> <td><strong>Causes</strong></td> <td> <ul> <li>Acute infection (viral or bacterial bronchiolitis, pneumonia) accounts for most episodes</li> </ul> </td> <td> <ul> <li>Typically occurs as a complication of a vaso-occlusive pain episode</li> <li>Bone marrow and fat emboli are more frequent in adults than children, although these are challenging to diagnose</li> <li>Pulmonary embolism or thrombosis</li> </ul> </td> </tr> <tr> <td><strong>Risk factors</strong></td> <td> <ul> <li>Hb SS or Hb S-beta<sup>0</sup>-thalasssemia genotype</li> <li>Prior ACS or vaso-occlusive episodes</li> <li>Winter months</li> <li>Asthma</li> <li>Exposure to environmental smoke</li> </ul> </td> <td> <ul> <li>Hb SS or Hb S-beta<sup>0</sup>-thalasssemia genotype</li> <li>Prior ACS or vaso-occlusive episodes</li> <li>Recurrent <span style="white-space: nowrap;">wheezing<sup>[1,2]</sup></span></li> <li>High WBC, hemoglobin</li> <li>Smoking</li> </ul> </td> </tr> <tr> <td><strong>Incidence</strong>*</td> <td> <ul> <li>32 per 100 patient-years (patients with <span style="white-space: nowrap;">asthma)<sup>[3]</sup></span></li> <li>16 per 100 patient-years (patients without <span style="white-space: nowrap;">asthma)<sup>[3]</sup></span></li> </ul> </td> <td> <ul> <li>9 per 100 <span style="white-space: nowrap;">patient-years<sup>[4]</sup></span></li> </ul> </td> </tr> <tr> <td><strong>Evaluation</strong></td> <td> <ul> <li>Examination including temperature, chest and abdomen, and any sites of pain</li> <li>Laboratory testing as appropriate<sup>¶</sup></li> <li>Chest imaging<sup>¶</sup></li> <li>Pulse oximetry<sup>¶</sup></li> <li>Consider other diagnoses (asthma, other infections)</li> </ul> </td> <td> <ul> <li>Examination including temperature, chest and abdomen, and any sites of pain</li> <li>Laboratory testing as appropriate<sup>¶</sup></li> <li>Chest imaging<sup>¶</sup></li> <li>Pulse oximetry<sup>¶</sup></li> <li>Consider other diagnoses (pulmonary embolism, vaso-occlusive pain, acute coronary syndrome/myocardial infarction)</li> </ul> </td> </tr> <tr> <td><strong>Management</strong></td> <td> <ul> <li>Pain control and active management of acute vaso-occlusive pain</li> <li>Respiratory support including supplemental oxygen if needed and incentive spirometry</li> <li>Antibiotics</li> <li>Transfusion for moderate to severe cases (simple or exchange)</li> <li>Supportive care (bronchodilators for wheezing or history of asthma)</li> <li>Post-discharge assessment for pulmonary function and assessment of aeroallergens</li> </ul> </td> <td> <ul> <li>Pain control and active management of acute vaso-occlusive pain</li> <li>Respiratory support including supplemental oxygen if needed and incentive spirometry; intubation may be required</li> <li>Antibiotics</li> <li>Transfusion for most cases (simple or exchange)</li> <li>Supportive care (fluids, bronchodilators for wheezing or history of asthma)</li> </ul> </td> </tr> <tr> <td><strong>Prognosis</strong></td> <td> <ul> <li>Death is rare in children with SCD who have an ACS <span style="white-space: nowrap;">episode<sup>[5]</sup></span></li> </ul> </td> <td> <ul> <li>Patients with rapidly progressive ACS: <span style="white-space: nowrap;">mortality 6%<sup>[5]</sup></span></li> <li>Patients without rapidly progressive ACS: <span style="white-space: nowrap;">mortality 0%<sup>[5]</sup></span></li> </ul> </td> </tr> <tr> <td><strong>Prevention</strong></td> <td> <ul> <li>Education</li> <li>Vaccinations</li> <li>Prophylactic penicillin</li> <li>Asthma treatment and control of environmental allergens</li> <li>Hydroxyurea</li> <li>Chronic transfusion if hydroxyurea is ineffective</li> </ul> </td> <td> <ul> <li>Education</li> <li>Vaccinations</li> <li>Asthma treatment</li> <li>Hydroxyurea</li> <li>Chronic transfusion if hydroxyurea is ineffective</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">All patients with suspected ACS should have chest imaging regardless of age. Causes, evaluation, and management are similar among children and adults, but the relative frequency differs. As examples, adults are more likely to have ACS as a complication of a vaso-occlusive pain episode while children are more likely to have a viral or bacterial infection or asthma. Refer to UpToDate topics for additional information and supporting evidence.</div><div class="graphic_footnotes"><p>Hb: hemoglobin; ACS: acute chest syndrome; WBC: white blood count; SCD: sickle cell disease; CBC: complete blood count; COVID-19: coronavirus disease 2019; CTPA: computed tomography with pulmonary angiography.</p>
<p>* Rates of ACS are highest in individuals with Hb SS or Hb S-beta<sup>0</sup>-thalassemia (approximately 3-fold higher than other genotypes), but individuals with any genotype can develop ACS, and ACS cannot be excluded based on genotype.</p>
		
	¶ Laboratory testing includes:
	<ul>
<li>
		CBC</li>
<li>Type and crossmatch</li>
<li>Hb S percentage</li>
<li>Metabolic panel</li>
<li>Infectious disease testing (cultures, COVID-19
		test, influenza test)
		</li>
</ul>
<p class="extra_spacing_top">Chest radiography is the standard imaging modality for diagnosing ACS. In some cases, other modalities such as chest ultrasound may be used if there are additional indications or local expertise. CTPA may be appropriate if pulmonary embolism or pulmonary thrombosis is suspected. Pulse oximetry is important, but arterial blood gas is rarely needed unless there is impending respiratory collapse or need for intubation.</p></div><div class="graphic_reference">References:
	<ol>
<li>Cohen RT, Madadi A, Blinder MA, et al. Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease. Am J Hematol 2011; 86:756.</li>
<li>Jakubowiak AJ, Richardson PG, Zimmerman T, et al. Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study. Br J Haematol 2012; 158:472.</li>
<li>Willen SM, Rodeghier M, DeBaun MR. Asthma in children with sickle cell disease. Curr Opin Pediatr 2019; 31:349.</li>
<li>Castro O, Brambilla DJ, Thorington B, et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. Blood 1994; 84:643.</li>
<li>Chaturvedi S, Ghafuri DL, Glassberg J, et al. Rapidly progressive acute chest syndrome in individuals with sickle cell anemia: a distinct acute chest syndrome phenotype. Am J Hematol 2016; 91:1185. </li>
</ol></div><div id="graphicVersion">Graphic 134346 Version 3.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
